This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox (CLX) Raises Dividend: What it Means for Investors
by Zacks Equity Research
Clorox's (CLX) strategy of incremental dividend growth not only bolsters shareholder income but also reinforces investor confidence in the company.
Here's Why Clorox (CLX) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Insights Into Clorox (CLX) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Clorox (CLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
Factors to Watch Before TreeHouse Foods' (THS) Q2 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) Q2 results are likely to reflect challenges such as the restart of the broth facility, along with the lag in pricing adjustments to counter cocoa inflation.
Kellanova (K) Q2 Earnings Coming Up: Key Factors to Consider
by Zacks Equity Research
Kellanova's (K) second-quarter performance is likely to reflect the impacts of elevated inflation rates and industry-wide elasticities. Unfavorable foreign currency rates pose a threat.
Tyson Foods (TSN) Q3 Earnings in the Cards: Things to Note
by Zacks Equity Research
Tyson Foods (TSN) Q3 performance will likely reflect gains from growing protein demand. However, a tight cattle supply environment might have been a spoilsport.
Procter & Gamble (PG) Q4 Earnings Top Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 2.19% and 0.91%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What Awaits for Pilgrim's Pride's (PPC) Q2 Earnings Release?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q2 performance will reflect gains from robust market momentum and improved efficiency. However, an elevated cost environment is a hurdle.
Service Corporation (SCI) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2024 performance will likely reflect gains from strength in the Cemetery segment. However, a rising interest rate environment poses a threat.
Can AB InBev (BUD) Deliver Q2 Earnings Beat Despite High Costs?
by Zacks Equity Research
AB InBev's (BUD) Q2 results are expected to reflect strong demand for its brand portfolio, pricing actions, premiumization and revenue management initiatives, offset by higher costs.
Can Clorox's (CLX) Pricing & Cost-Saving Plan Aid Q4 Earnings?
by Zacks Equity Research
Clorox's (CLX) Q4 results are expected to reflect gains from pricing strategies and cost-saving initiatives, as well as progress on the IGNITE strategy, amid high SG&A expenses.
Hershey's (HSY) Q2 Earnings in the Cards: Key Things to Note
by Zacks Equity Research
Hershey's (HSY) Q2 results are likely to reflect gains from brand strength, but high commodity costs, increased selling, marketing and administrative expenses and currency volatility are concerns.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Is Procter & Gamble (PG) a Smart Investment Pre-Q4 Earnings?
by Rajani Lohia
While P&G's (PG) strong financial performance and strategic initiatives provide a solid foundation for growth in Q4, the external risks justify a neutral stance on its investment potential.
Church & Dwight (CHD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vita Coco Company (COCO) to Post Q2 Earnings: Things to Note
by Zacks Equity Research
Vita Coco Company's (COCO) second-quarter 2024 results are likely to reflect gains from brand strength and share in the coconut water category.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Archer Daniels (ADM) Gears Up for Q2 Earnings: Things to Note
by Zacks Equity Research
Archer Daniels' (ADM) second-quarter 2024 results are likely to reflect the impacts of tough market conditions and higher costs. A soft Nutrition segment is also a concern.
Sysco's (SYY) Q4 Earnings in the Cards: Key Things to Note
by Zacks Equity Research
Sysco's (SYY) Q4 results are likely to reflect gains from the company's efforts to enhance volumes and improve efficiency through supply-chain productivity and cost-containment efforts.
Mondelez (MDLZ) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
Mondelez's (MDLZ) Q2 results are likely to reflect the impacts of a tough operating landscape and input cost inflation, while pricing is likely to have aided the performance.
Will Strong Volume & Pricing Aid Colgate's (CL) Q2 Earnings?
by Zacks Equity Research
Solid volume and pricing, and growth across categories and regions are likely to aid Colgate's (CL) Q2 results. Softness in China, high raw material costs and FX inflation are concerning.
Will Lamb Weston (LW) Top Estimates in Q4 Earnings Release?
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter results are likely to reflect gains from a favorable pricing environment amid volume concerns.
Columbia Sportswear (COLM) Q2 Earnings Coming Up: Things to Note
by Zacks Equity Research
Columbia Sportswear's (COLM) Q2 results are likely to reflect the impacts of a tough operating landscape in North America, leading to soft demand, along with high SG&A costs.
Procter & Gamble (PG) Hits 52-Week High: Buy, Hold or Sell?
by Rajani Lohia
After Procter & Gamble (PG) hits a 52-week high, we assess whether the current level warrants an opportunity to accumulate shares, hold positions or book profits.